{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:06:04Z","timestamp":1791194764132,"version":"4.1.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/nrneurol.2012.236","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T08:53:08Z","timestamp":1354006388000},"page":"25-34","source":"Crossref","is-referenced-by-count":387,"title":["Deciphering the mechanism underlying late-onset Alzheimer disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Dimitrije","family":"Krstic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Knuesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BFnrneurol2012236_CR1","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri, C. P. et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112\u20132117 (2005).","journal-title":"Lancet"},{"key":"BFnrneurol2012236_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"RJ Castellani","year":"2010","unstructured":"Castellani, R. J., Rolston, R. K. & Smith, M. A. Alzheimer disease. Dis. Mon. 56, 484\u2013546 (2010).","journal-title":"Dis. Mon."},{"key":"BFnrneurol2012236_CR3","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrneurol2012236_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"key":"BFnrneurol2012236_CR5","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup, K. Reimagining Alzheimer's disease\u2014an age-based hypothesis. J. Neurosci. 30, 16755\u201316762 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"BFnrneurol2012236_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2012236_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2012236_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2011-110824","volume":"28","author":"A Gerrish","year":"2012","unstructured":"Gerrish, A. et al. The role of variation at A\u03b2PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J. Alzheimers Dis. 28, 377\u2013387 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2012236_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1742-2094-9-179","volume":"9","author":"DH Cribbs","year":"2012","unstructured":"Cribbs, D. H. et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J. Neuroinflammation 9, 179 (2012).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/13550280290100969","volume":"8","author":"PL McGeer","year":"2002","unstructured":"McGeer, P. L. & McGeer, E. G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8, 529\u2013538 (2002).","journal-title":"J. Neurovirol."},{"key":"BFnrneurol2012236_CR12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager, W. et al. A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 68, 930\u2013941 (2010).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2012236_CR13","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005\u20131015 (2006).","journal-title":"Nat. Med."},{"key":"BFnrneurol2012236_CR14","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","volume":"26","author":"U Meyer","year":"2006","unstructured":"Meyer, U. et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26, 4752\u20134762 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.npp.1301413","volume":"33","author":"U Meyer","year":"2008","unstructured":"Meyer, U. et al. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33, 441\u2013456 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"BFnrneurol2012236_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2007.08.011","volume":"30","author":"I Knuesel","year":"2009","unstructured":"Knuesel, I. et al. Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol. Aging 30, 697\u2013716 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-9-151","volume":"9","author":"D Krstic","year":"2012","unstructured":"Krstic, D. et al. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J. Neuroinflammation 9, 151 (2012).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes, C. et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768\u2013774 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol2012236_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","volume":"17","author":"JG Sheng","year":"1996","unstructured":"Sheng, J. G. et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761\u2013766 (1996).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR20","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1111\/j.1460-9568.2012.08154.x","volume":"35","author":"J Doehner","year":"2012","unstructured":"Doehner, J., Genoud, C., Imhof, C., Krstic, D. & Knuesel, I. Extrusion of misfolded and aggregated proteins\u2014a protective strategy of aging neurons? Eur. J. Neurosci. 35, 1938\u20131950 (2012).","journal-title":"Eur. J. Neurosci."},{"key":"BFnrneurol2012236_CR21","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JAD-2010-1333","volume":"19","author":"J Doehner","year":"2010","unstructured":"Doehner, J., Madhusudan, A., Konietzko, U., Fritschy, J. M. & Knuesel, I. Co-localization of Reelin and proteolytic A\u03b2PP fragments in hippocampal plaques in aged wild-type mice. J. Alzheimers Dis. 19, 1339\u20131357 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2012236_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00429-007-0153-1","volume":"212","author":"JC Fiala","year":"2007","unstructured":"Fiala, J. C., Feinberg, M., Peters, A. & Barbas, H. Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments. Brain Struct. Funct. 212, 195\u2013207 (2007).","journal-title":"Brain Struct. Funct."},{"key":"BFnrneurol2012236_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1750-3639.1991.tb00672.x","volume":"1","author":"DL Price","year":"1991","unstructured":"Price, D. L. et al. Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathol. 1, 287\u2013296 (1991).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2012236_CR24","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.1523\/JNEUROSCI.0560-11.2011","volume":"31","author":"NM Kanaan","year":"2011","unstructured":"Kanaan, N. M. et al. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 31, 9858\u20139868 (2011).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR25","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","volume":"32","author":"K Shahpasand","year":"2012","unstructured":"Shahpasand, K. et al. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J. Neurosci. 32, 2430\u20132441 (2012).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0854.2007.00695.x","volume":"9","author":"OA Shemesh","year":"2008","unstructured":"Shemesh, O. A., Erez, H., Ginzburg, I. & Spira, M. E. Tau-induced traffic jams reflect organelles accumulation at points of microtubule polar mismatching. Traffic 9, 458\u2013471 (2008).","journal-title":"Traffic"},{"key":"BFnrneurol2012236_CR27","doi-asserted-by":"publisher","first-page":"e1002918","DOI":"10.1371\/journal.pgen.1002918","volume":"8","author":"K Iijima-Ando","year":"2012","unstructured":"Iijima-Ando, K. et al. Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. PLoS Genet. 8, e1002918 (2012).","journal-title":"PLoS Genet."},{"key":"BFnrneurol2012236_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12264-011-1736-7","volume":"27","author":"AW Xiao","year":"2011","unstructured":"Xiao, A. W. et al. The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease. Neurosci. Bull. 27, 287\u2013299 (2011).","journal-title":"Neurosci. Bull."},{"key":"BFnrneurol2012236_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"BFnrneurol2012236_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon, R. A. et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64, 113\u2013122 (2005).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2012236_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2011.01.021","volume":"43","author":"RA Nixon","year":"2011","unstructured":"Nixon, R. A. & Yang, D. S. Autophagy failure in Alzheimer's disease\u2014locating the primary defect. Neurobiol. Dis. 43, 38\u201345 (2011).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2012236_CR32","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","volume":"85","author":"N Sergeant","year":"2003","unstructured":"Sergeant, N. et al. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J. Neurochem. 85, 1581\u20131591 (2003).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2012236_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jnr.490310305","volume":"31","author":"PL McGeer","year":"1992","unstructured":"McGeer, P. L. et al. Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31, 428\u2013442 (1992).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneurol2012236_CR34","first-page":"1021","volume":"317","author":"G Perry","year":"1989","unstructured":"Perry, G. et al. Immunolocalization of the amyloid precursor protein within the senile plaque. Prog. Clin. Biol. Res. 317, 1021\u20131025 (1989).","journal-title":"Prog. Clin. Biol. Res."},{"key":"BFnrneurol2012236_CR35","unstructured":"Malamud, N. & Hirano, A. Atlas of Neuropathology 2nd edn 314\u2013327 (University of California Press, Berkley, Los Angeles, London, 1974)."},{"key":"BFnrneurol2012236_CR36","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1523\/JNEUROSCI.0418-10.2010","volume":"30","author":"S Kocherhans","year":"2010","unstructured":"Kocherhans, S. et al. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J. Neurosci. 30, 9228\u20139240 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer, P. L., Schulzer, M. & McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425\u2013432 (1996).","journal-title":"Neurology"},{"key":"BFnrneurol2012236_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt, R. et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu\u2013Asia Aging Study. Ann. Neurol. 52, 168\u2013174 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2012236_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart, M. J. et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch. Neurol. 61, 668\u2013672 (2004).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2012236_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.wad.0000165511.52746.1f","volume":"19","author":"N Dunn","year":"2005","unstructured":"Dunn, N., Mullee, M., Perry, V. H. & Holmes, C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis. Assoc. Disord. 19, 91\u201394 (2005).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnrneurol2012236_CR41","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","volume":"289","author":"PS Aisen","year":"2003","unstructured":"Aisen, P. S. et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289, 2819\u20132826 (2003).","journal-title":"JAMA"},{"key":"BFnrneurol2012236_CR42","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","volume":"30","author":"LJ Thal","year":"2005","unstructured":"Thal, L. J. et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30, 1204\u20131215 (2005).","journal-title":"Neuropsychopharmacology"},{"key":"BFnrneurol2012236_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner, J. C. et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement. 7, 402\u2013411 (2011).","journal-title":"Alzheimers Dement."},{"key":"BFnrneurol2012236_CR44","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/WNL.38.11.1682","volume":"38","author":"H Crystal","year":"1988","unstructured":"Crystal, H. et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38, 1682\u20131687 (1988).","journal-title":"Neurology"},{"key":"BFnrneurol2012236_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/geront\/37.2.150","volume":"37","author":"DA Snowdon","year":"1997","unstructured":"Snowdon, D. A. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 37, 150\u2013156 (1997).","journal-title":"Gerontologist"},{"key":"BFnrneurol2012236_CR46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00005072-199655100-00008","volume":"55","author":"LF Lue","year":"1996","unstructured":"Lue, L. F., Brachova, L., Civin, W. H. & Rogers, J. Inflammation, A\u03b2 deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55, 1083\u20131088 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2012236_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-2011-101815","volume":"25","author":"K Morimoto","year":"2011","unstructured":"Morimoto, K. et al. Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. J. Alzheimers Dis. 25, 59\u201376 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2012236_CR48","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","volume":"28","author":"A Parachikova","year":"2007","unstructured":"Parachikova, A. et al. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 28, 1821\u20131833 (2007).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.expneurol.2004.03.016","volume":"188","author":"C Schwab","year":"2004","unstructured":"Schwab, C., Hosokawa, M. & McGeer, P. L. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp. Neurol. 188, 52\u201364 (2004).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2012236_CR50","doi-asserted-by":"publisher","first-page":"e27291","DOI":"10.1371\/journal.pone.0027291","volume":"6","author":"CL Maarouf","year":"2011","unstructured":"Maarouf, C. L. et al. Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging. PLoS One 6, e27291 (2011).","journal-title":"PLoS One"},{"key":"BFnrneurol2012236_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-2009-1151","volume":"18","author":"RJ Castellani","year":"2009","unstructured":"Castellani, R. J. et al. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-\u03b2 protein precursor and amyloid-\u03b2. J. Alzheimers Dis. 18, 447\u2013452 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2012236_CR52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","volume":"32","author":"P Edison","year":"2008","unstructured":"Edison, P. et al. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 32, 412\u2013419 (2008).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2012236_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","volume":"38","author":"M Yokokura","year":"2011","unstructured":"Yokokura, M. et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 38, 343\u2013351 (2011).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"BFnrneurol2012236_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.ede.0000152116.32580.24","volume":"16","author":"K Andersen","year":"2005","unstructured":"Andersen, K., Lolk, A., Kragh-Sorensen, P., Petersen, N. E. & Green, A. Depression and the risk of Alzheimer disease. Epidemiology 16, 233\u2013238 (2005).","journal-title":"Epidemiology"},{"key":"BFnrneurol2012236_CR55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-2005-8305","volume":"8","author":"K Balakrishnan","year":"2005","unstructured":"Balakrishnan, K. et al. Plasma A\u03b242 correlates positively with increased body fat in healthy individuals. J. Alzheimers Dis. 8, 269\u2013282 (2005).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2012236_CR56","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1042\/BST0331041","volume":"33","author":"GJ Biessels","year":"2005","unstructured":"Biessels, G. J. & Kappelle, L. J. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem. Soc. Trans. 33, 1041\u20131044 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrneurol2012236_CR57","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(04)15900-X","volume":"363","author":"I Casserly","year":"2004","unstructured":"Casserly, I. & Topol, E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139\u20131146 (2004).","journal-title":"Lancet"},{"key":"BFnrneurol2012236_CR58","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446\u2013457 (2010).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2012236_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2009.08.013","volume":"216","author":"AR Kamer","year":"2009","unstructured":"Kamer, A. R. et al. TNF-\u03b1 and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J. Neuroimmunol. 216, 92\u201397 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2012236_CR60","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby, R. L., Crocco, E., Acevedo, A., John, V. & Loewenstein, D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63, 530\u2013538 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnrneurol2012236_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S1466252308001448","volume":"9","author":"I Tizard","year":"2008","unstructured":"Tizard, I. Sickness behavior, its mechanisms and significance. Anim. Health Res. Rev. 9, 87\u201399 (2008).","journal-title":"Anim. Health Res. Rev."},{"key":"BFnrneurol2012236_CR62","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol2012236_CR63","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bbi.2006.12.007","volume":"21","author":"C Cunningham","year":"2007","unstructured":"Cunningham, C., Campion, S., Teeling, J., Felton, L. & Perry, V. H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav. Immun. 21, 490\u2013502 (2007).","journal-title":"Brain Behav. Immun."},{"key":"BFnrneurol2012236_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroimage.2012.06.055","volume":"63","author":"J Hannestad","year":"2012","unstructured":"Hannestad, J. et al. Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 63, 232\u2013239 (2012).","journal-title":"Neuroimage"},{"key":"BFnrneurol2012236_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7","volume":"48","author":"F Pitossi","year":"1997","unstructured":"Pitossi, F., del Rey, A., Kabiersch, A. & Besedovsky, H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J. Neurosci. Res. 48, 287\u2013298 (1997).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneurol2012236_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00213-008-1166-z","volume":"199","author":"H Anisman","year":"2008","unstructured":"Anisman, H., Gibb, J. & Hayley, S. Influence of continuous infusion of interleukin-1\u03b2 on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl.) 199, 231\u2013244 (2008).","journal-title":"Psychopharmacology (Berl.)"},{"key":"BFnrneurol2012236_CR67","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-2094-4-4","volume":"4","author":"AW Lemstra","year":"2007","unstructured":"Lemstra, A. W. et al. Microglia activation in sepsis: a case\u2013control study. J. Neuroinflammation 4, 4 (2007).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1742-2094-9-146","volume":"9","author":"U Puentener","year":"2012","unstructured":"Puentener, U., Booth, S. G., Perry, V. H. & Teeling, J. L. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J. Neuroinflammation 9, 146 (2012).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR69","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/77046","volume":"25","author":"CK Lee","year":"2000","unstructured":"Lee, C. K., Weindruch, R. & Prolla, T. A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25, 294\u2013297 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2012236_CR70","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nature02661","volume":"429","author":"T Lu","year":"2004","unstructured":"Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883\u2013891 (2004).","journal-title":"Nature"},{"key":"BFnrneurol2012236_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","volume":"128","author":"C Franceschi","year":"2007","unstructured":"Franceschi, C. et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92\u2013105 (2007).","journal-title":"Mech. Ageing Dev."},{"key":"BFnrneurol2012236_CR72","doi-asserted-by":"publisher","unstructured":"Cunningham, C. & Maclullich, A. M. At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain. Behav. Immun. http:\/\/dx.doi.org\/10.1016\/j.bbi.2012.07.012 .","DOI":"10.1016\/j.bbi.2012.07.012"},{"key":"BFnrneurol2012236_CR73","doi-asserted-by":"publisher","unstructured":"Norden, D. M. & Godbout, J. P. Microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. http:\/\/dx.doi.org\/10.1111\/j.1365-2990.2012.01306.x .","DOI":"10.1111\/j.1365-2990.2012.01306.x"},{"key":"BFnrneurol2012236_CR74","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/icb\/icp009","volume":"49","author":"AM Wynne","year":"2009","unstructured":"Wynne, A. M., Henry, C. J. & Godbout, J. P. Immune and behavioral consequences of microglial reactivity in the aged brain. Integr. Comp. Biol. 49, 254\u2013266 (2009).","journal-title":"Integr. Comp. Biol."},{"key":"BFnrneurol2012236_CR75","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.neurobiolaging.2005.03.010","volume":"27","author":"RM Barrientos","year":"2006","unstructured":"Barrientos, R. M. et al. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging 27, 723\u2013732 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR76","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1096\/fj.05-3776fje","volume":"19","author":"JP Godbout","year":"2005","unstructured":"Godbout, J. P. et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19, 1329\u20131331 (2005).","journal-title":"FASEB J."},{"key":"BFnrneurol2012236_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbi.2008.07.002","volume":"23","author":"RM Barrientos","year":"2009","unstructured":"Barrientos, R. M. et al. Time course of hippocampal IL-1 \u03b2 and memory consolidation impairments in aging rats following peripheral infection. Brain. Behav. Immun. 23, 46\u201354 (2009).","journal-title":"Brain. Behav. Immun."},{"key":"BFnrneurol2012236_CR78","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbi.2008.09.002","volume":"23","author":"CJ Henry","year":"2009","unstructured":"Henry, C. J., Huang, Y., Wynne, A. M. & Godbout, J. P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1\u03b2 and anti-inflammatory IL-10 cytokines. Brain. Behav. Immun. 23, 309\u2013317 (2009).","journal-title":"Brain. Behav. Immun."},{"key":"BFnrneurol2012236_CR79","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CY Lee","year":"2010","unstructured":"Lee, C. Y. & Landreth, G. E. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117, 949\u2013960 (2010).","journal-title":"J. Neural Transm."},{"key":"BFnrneurol2012236_CR80","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl, S. A. et al. Formation and maintenance of Alzheimer's disease \u03b2-amyloid plaques in the absence of microglia. Nat. Neurosci. 12, 1361\u20131363 (2009).","journal-title":"Nat. Neurosci."},{"key":"BFnrneurol2012236_CR81","doi-asserted-by":"publisher","first-page":"32301","DOI":"10.1074\/jbc.274.45.32301","volume":"274","author":"H Chung","year":"1999","unstructured":"Chung, H., Brazil, M. I., Soe, T. T. & Maxfield, F. R. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid \u03b2-peptide by microglial cells. J. Biol. Chem. 274, 32301\u201332308 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2012236_CR82","doi-asserted-by":"publisher","first-page":"195.e1","DOI":"10.1016\/j.neurobiolaging.2010.05.008","volume":"33","author":"EG Njie","year":"2012","unstructured":"Njie, E. G. et al. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol. Aging 33, 195.e1\u2013195.e12 (2012).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004010050664","volume":"94","author":"JG Sheng","year":"1997","unstructured":"Sheng, J. G., Mrak, R. E. & Griffin, W. S. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94, 1\u20135 (1997).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2012236_CR84","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cell.2008.04.037","volume":"133","author":"F Peri","year":"2008","unstructured":"Peri, F. & Nusslein-Volhard, C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 133, 916\u2013927 (2008).","journal-title":"Cell"},{"key":"BFnrneurol2012236_CR85","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1749-6632.1988.tb27086.x","volume":"540","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Tago, H. & McGeer, E. G. Occurrence of HLA-DR reactive microglia in Alzheimer's disease. Ann. NY Acad. Sci. 540, 319\u2013323 (1988).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneurol2012236_CR86","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit, W. J., Braak, H., Xue, Q. S. & Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475\u2013485 (2009).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2012236_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1742-2094-8-171","volume":"8","author":"JJ Hoozemans","year":"2011","unstructured":"Hoozemans, J. J., Rozemuller, A. J., van Haastert, E. S., Eikelenboom, P. & van Gool, W. A. Neuroinflammation in Alzheimer's disease wanes with age. J. Neuroinflammation 8, 171 (2011).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19\u201331 (2010).","journal-title":"Neuron"},{"key":"BFnrneurol2012236_CR89","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1096\/fj.08-123877","volume":"23","author":"P Gorlovoy","year":"2009","unstructured":"Gorlovoy, P., Larionov, S., Pham, T. T. & Neumann, H. Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J. 23, 2502\u20132513 (2009).","journal-title":"FASEB J."},{"key":"BFnrneurol2012236_CR90","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li, Y., Liu, L., Barger, S. W. & Griffin, W. S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23, 1605\u20131611 (2003).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR91","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/j.1582-4934.2012.01556.x","volume":"16","author":"H Sarlus","year":"2012","unstructured":"Sarlus, H. et al. Allergy influences the inflammatory status of the brain and enhances tau phosphorylation. J. Cell. Mol. Med. 16, 2401\u20132412 (2012).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrneurol2012236_CR92","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1242\/jcs.01558","volume":"117","author":"GV Johnson","year":"2004","unstructured":"Johnson, G. V. & Stoothoff, W. H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117, 5721\u20135729 (2004).","journal-title":"J. Cell Sci."},{"key":"BFnrneurol2012236_CR93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/ncb1528","volume":"9","author":"TA Fulga","year":"2007","unstructured":"Fulga, T. A. et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol. 9, 139\u2013148 (2007).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneurol2012236_CR94","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","volume":"2","author":"K Iqbal","year":"1986","unstructured":"Iqbal, K. et al. Defective brain microtubule assembly in Alzheimer's disease. Lancet 2, 421\u2013426 (1986).","journal-title":"Lancet"},{"key":"BFnrneurol2012236_CR95","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","volume":"55","author":"RD Terry","year":"1996","unstructured":"Terry, R. D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55, 1023\u20131025 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2012236_CR96","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s004010050420","volume":"91","author":"D Praprotnik","year":"1996","unstructured":"Praprotnik, D., Smith, M. A., Richey, P. L., Vinters, H. V. & Perry, G. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol. 91, 226\u2013235 (1996).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2012236_CR97","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.biochem.75.103004.142637","volume":"75","author":"GB Stokin","year":"2006","unstructured":"Stokin, G. B. & Goldstein, L. S. Axonal transport and Alzheimer's disease. Ann. Rev. Biochem. 75, 607\u2013627 (2006).","journal-title":"Ann. Rev. Biochem."},{"key":"BFnrneurol2012236_CR98","first-page":"415","volume":"148","author":"A Stieber","year":"1996","unstructured":"Stieber, A., Mourelatos, Z. & Gonatas, N. K. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Pathol. 148, 415\u2013426 (1996).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2012236_CR99","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1523\/JNEUROSCI.4272-06.2007","volume":"27","author":"O Lazarov","year":"2007","unstructured":"Lazarov, O. et al. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J. Neurosci. 27, 7011\u20137020 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR100","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1523\/JNEUROSCI.21-03-00834.2001","volume":"21","author":"G Pigino","year":"2001","unstructured":"Pigino, G., Pelsman, A., Mori, H. & Busciglio, J. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J. Neurosci. 21, 834\u2013842 (2001).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR101","doi-asserted-by":"publisher","unstructured":"Rodrigues, E. M., Weissmiller, A. M. & Goldstein, L. S. Enhanced \u03b2-secretase processing alters APP axonal transport and leads to axonal defects. Hum. Mol. Genet. http:\/\/dx.doi.org\/10.1093\/hmg\/dds297 .","DOI":"10.1093\/hmg\/dds297"},{"key":"BFnrneurol2012236_CR102","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64788-8","volume":"157","author":"I Tesseur","year":"2000","unstructured":"Tesseur, I. et al. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol. 157, 1495\u20131510 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2012236_CR103","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70, 960\u2013969 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2012236_CR104","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307\u2013318 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneurol2012236_CR105","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","volume":"142","author":"U Seifert","year":"2010","unstructured":"Seifert, U. et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613\u2013624 (2010).","journal-title":"Cell"},{"key":"BFnrneurol2012236_CR106","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1471-4159.2007.04787.x","volume":"103","author":"MP Gavilan","year":"2007","unstructured":"Gavilan, M. P. et al. Molecular and cellular characterization of the age-related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons. J. Neurochem. 103, 984\u2013996 (2007).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2012236_CR107","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1742-2094-9-87","volume":"9","author":"C Pintado","year":"2012","unstructured":"Pintado, C. et al. Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus. J. Neuroinflammation 9, 87 (2012).","journal-title":"J. Neuroinflammation"},{"key":"BFnrneurol2012236_CR108","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0169-328X(92)90202-M","volume":"16","author":"G Forloni","year":"1992","unstructured":"Forloni, G., Demicheli, F., Giorgi, S., Bendotti, C. & Angeretti, N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 16, 128\u2013134 (1992).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrneurol2012236_CR109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0969-9961(03)00069-X","volume":"14","author":"JG Sheng","year":"2003","unstructured":"Sheng, J. G. et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid \u03b2 peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133\u2013145 (2003).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2012236_CR110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0304-3940(94)90066-3","volume":"176","author":"WS Griffin","year":"1994","unstructured":"Griffin, W. S. et al. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. Lett. 176, 133\u2013136 (1994).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2012236_CR111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1179\/016164108X323771","volume":"31","author":"T Itoh","year":"2009","unstructured":"Itoh, T. et al. Expression of amyloid precursor protein after rat traumatic brain injury. Neurol. Res. 31, 103\u2013109 (2009).","journal-title":"Neurol. Res."},{"key":"BFnrneurol2012236_CR112","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","volume":"22","author":"VE Johnson","year":"2012","unstructured":"Johnson, V. E., Stewart, W. & Smith, D. H. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 22, 142\u2013149 (2012).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2012236_CR113","doi-asserted-by":"publisher","unstructured":"Mouzon, B. C. et al. Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. J. Neurotrauma http:\/\/dx.doi.org\/10.1089\/neu.2012.2498 .","DOI":"10.1089\/neu.2012.2498"},{"key":"BFnrneurol2012236_CR114","doi-asserted-by":"publisher","first-page":"e18754","DOI":"10.1371\/journal.pone.0018754","volume":"6","author":"TW Groemer","year":"2011","unstructured":"Groemer, T. W. et al. Amyloid precursor protein is trafficked and secreted via synaptic vesicles. PLoS One 6, e18754 (2011).","journal-title":"PLoS One"},{"key":"BFnrneurol2012236_CR115","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1073\/pnas.87.4.1561","volume":"87","author":"EH Koo","year":"1990","unstructured":"Koo, E. H. et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl Acad. Sci. USA 87, 1561\u20131565 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2012236_CR116","doi-asserted-by":"publisher","first-page":"e7134","DOI":"10.1371\/journal.pone.0007134","volume":"4","author":"J Morales-Corraliza","year":"2009","unstructured":"Morales-Corraliza, J. et al. In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the \u03b2-amyloid depositing mice. PLoS One 4, e7134 (2009).","journal-title":"PLoS One"},{"key":"BFnrneurol2012236_CR117","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-8993(95)00729-A","volume":"695","author":"N Ichihara","year":"1995","unstructured":"Ichihara, N. et al. Axonal degeneration promotes abnormal accumulation of amyloid \u03b2-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695, 173\u2013178 (1995).","journal-title":"Brain Res."},{"key":"BFnrneurol2012236_CR118","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1523\/JNEUROSCI.6412-10.2011","volume":"31","author":"S Lee","year":"2011","unstructured":"Lee, S., Sato, Y. & Nixon, R. A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31, 7817\u20137830 (2011).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR119","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/emboj.2011.119","volume":"30","author":"SW Weyer","year":"2011","unstructured":"Weyer, S. W. et al. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 30, 2266\u20132280 (2011).","journal-title":"EMBO J."},{"key":"BFnrneurol2012236_CR120","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"GB Stokin","year":"2005","unstructured":"Stokin, G. B. et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282\u20131288 (2005).","journal-title":"Science"},{"key":"BFnrneurol2012236_CR121","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00401-006-0041-4","volume":"111","author":"O Wirths","year":"2006","unstructured":"Wirths, O., Weis, J., Szczygielski, J., Multhaup, G. & Bayer, T. A. Axonopathy in an APP\/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol. 111, 312\u2013319 (2006).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2012236_CR122","first-page":"1358","volume":"145","author":"LJ Martin","year":"1994","unstructured":"Martin, L. J., Pardo, C. A., Cork, L. C. & Price, D. L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358\u20131381 (1994).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2012236_CR123","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu, W. H. et al. Macroautophagy\u2014a novel \u03b2-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell. Biol. 171, 87\u201398 (2005).","journal-title":"J. Cell. Biol."},{"key":"BFnrneurol2012236_CR124","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1073\/pnas.87.10.3861","volume":"87","author":"AM Cataldo","year":"1990","unstructured":"Cataldo, A. M. & Nixon, R. A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl Acad. Sci. USA 87, 3861\u20133865 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2012236_CR125","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/bc.2011.054","volume":"392","author":"I Schechter","year":"2011","unstructured":"Schechter, I. & Ziv, E. Cathepsins S, B and L with aminopeptidases display \u03b2-secretase activity associated with the pathogenesis of Alzheimer's disease. Biol. Chem. 392, 555\u2013569 (2011).","journal-title":"Biol. Chem."},{"key":"BFnrneurol2012236_CR126","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin, M. et al. Soluble amyloid \u03b2-protein dimers isolated from Alzheimer cortex directly induce tau hyperphosphorylation and neuritic degeneration. Proc. Natl Acad. Sci. USA 108, 5819\u20135824 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2012236_CR127","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht, W. J. et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527\u20132534 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR128","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.neuroscience.2006.08.019","volume":"143","author":"W Zhou","year":"2006","unstructured":"Zhou, W., Scott, S. A., Shelton, S. B. & Crutcher, K. A. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 143, 689\u2013701 (2006).","journal-title":"Neuroscience"},{"key":"BFnrneurol2012236_CR129","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/brain\/awn312","volume":"132","author":"R Adalbert","year":"2009","unstructured":"Adalbert, R. et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 132, 402\u2013416 (2009).","journal-title":"Brain"},{"key":"BFnrneurol2012236_CR130","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A. & Mufson, E. J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27, 1372\u20131384 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012236_CR131","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1523\/JNEUROSCI.6338-11.2012","volume":"32","author":"AL Misko","year":"2012","unstructured":"Misko, A. L., Sasaki, Y., Tuck, E., Milbrandt, J. & Baloh, R. H. Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration. J. Neurosci. 32, 4145\u20134155 (2012).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR132","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner, L. M. & Gotz, J. Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65\u201372 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol2012236_CR133","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000017104","volume":"10","author":"DM Yilmazer-Hanke","year":"1999","unstructured":"Yilmazer-Hanke, D. M. & Hanke, J. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Dement. Geriatr. Cogn. Disord. 10, 70\u201376 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"BFnrneurol2012236_CR134","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0014-5793(94)00259-2","volume":"344","author":"ML Schmidt","year":"1994","unstructured":"Schmidt, M. L., DiDario, A. G., Lee, V. M. & Trojanowski, J. Q. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 344, 69\u201373 (1994).","journal-title":"FEBS Lett."},{"key":"BFnrneurol2012236_CR135","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"A de Calignon","year":"2010","unstructured":"de Calignon, A. et al. Caspase activation precedes and leads to tangles. Nature 464, 1201\u20131204 (2010).","journal-title":"Nature"},{"key":"BFnrneurol2012236_CR136","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.20-08-02825.2000","volume":"20","author":"A Buki","year":"2000","unstructured":"Buki, A., Okonkwo, D. O., Wang, K. K. & Povlishock, J. T. Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20, 2825\u20132834 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012236_CR137","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/nbdi.2002.0549","volume":"11","author":"TT Rohn","year":"2002","unstructured":"Rohn, T. T. et al. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11, 341\u2013354 (2002).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2012236_CR138","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2353\/ajpath.2007.070345","volume":"171","author":"K Leroy","year":"2007","unstructured":"Leroy, K. et al. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am. J. Pathol. 171, 976\u2013992 (2007).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.236","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:09:00Z","timestamp":1684469340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2012.236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":138,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFnrneurol2012236"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2012.236","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}